Fig. 8From: Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage responseSurvival analysis of POLR3D. Homozygous deletion of POLR3D (which is observed in the 8% of breast cancer cases), results in a significantly better disease-free survivalBack to article page